Friday
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Location: Grand Ballroom West, 3rd Floor
Moderators:Caron B. Rockman, MD / James H. Black, III, MD  
SESSION 93 SCHEDULE
ANTIPLATELET REGIMENS
2:36 PM - 2:41 PM Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs
  Presenter(s):David H. Stone, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:42 PM - 2:47 PM Current Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE: How Are DOACs Useful
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:48 PM - 2:53 PM What Is The Best Medical Treatment After Carotid, Aortic And Lower Extremity Endovascular Treatments
  Presenter(s):Maciej L. Dryjski , MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:54 PM - 2:59 PM Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem
  Presenter(s):Karthik Kasirajan, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS
3:00 PM - 3:05 PM Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Why These Treatments Are Underutilized – Especially In Women: Statin Intolerance Has Been Over Emphasized: LDL-C Should Be Monitored And Treated To An Optimal Level
  Presenter(s):Christian A. Behrendt, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:06 PM - 3:11 PM The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help: Will An Oral PCSK-9 Inhibitor Be Available
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:12 PM - 3:17 PM Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimide, (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol)
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:18 PM - 3:23 PM Value And Limitations Of Statins And Non-Statin Lipid Lowering Agents In Patients With Carotid Artery Stenosis
  Presenter(s):Kosmas I. Paraskevas, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:24 PM - 3:32 PM Panel Discussion
3:32 PM - 3:37 PM Diagnosis And Treatment Of Buerger’s Disease In 2023: Does It Exist Or Is It Just A Variant Of Atherosclerosis
  Presenter(s):Kamphol Laohapensang, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:38 PM - 3:43 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:44 PM - 3:49 PM Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help
  Presenter(s):Martin Björck, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:56 PM - 4:00 PM Panel Discussion (All Session 93 Topics)
END OF SESSION 93
previous next